NFE2L2 and Alzheimer disease: A pair of non-electrophilic NRF2-KEAP1 PPIs, NXPZ-2 and POZL, discovered by the same group, have both been shown to ameliorate AD phenotypes in Aβ-injected or APP/PS1 mice, respectively (Sun et al., 2020; Sun et al., 2023).